Navigation Links
Stem Cell Transplants in Mice Show Promise for Lou Gehrig's Disease

WEDNESDAY, Jan. 9 (HealthDay News) -- Stem cells may one day hold promise for a new treatment for people with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, new animal research suggests.

A study of mice found that stem cell transplantation extended their lifespan by 20 days and improved their neuromuscular function by 15 percent.

"There have been remarkable strides in stem cell transplantation when it comes to other diseases, such as cancer and heart failure," study author Dr. Stefania Corti, of the University of Milan in Italy, said in a news release from the American Academy of Neurology.

"ALS is a fatal, progressive, degenerative disease that currently has no cure," Corti said. "Stem cell transplants may represent a promising avenue for effective cell-based treatment for ALS and other neurodegenerative diseases."

The mice involved in the study had an animal version of ALS. They were injected with human neural stem cells taken from human induced pluripotent stem cells -- adult cells genetically reprogrammed to resemble embryonic stem cells.

These injected stem cells traveled to the spinal cord of the mice, where they matured and multiplied, improving the rodents' lifespan and neuromuscular function.

"Our study shows promise for testing stem cell transplantation in human clinical trials," Corti concluded.

Results achieved in animal tests, however, do not necessarily apply to humans.

The study's findings, released Jan. 9, are scheduled for presentation in March at the American Academy of Neurology's annual meeting in San Diego. Data and conclusions presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

People with ALS eventually lose their strength and cannot move or breathe. The American baseball player Lou Gehrig died of the disease in 1941.

More information

The U.S. National Institute of Neurological Disorders and Stroke provides more information on Lou Gehrig's disease.

-- Mary Elizabeth Dallas

SOURCE: American Academy of Neurology, news release, Jan. 9, 2013

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Boomers With Hepatitis C Boosting Demand for Liver Transplants
2. Brain cell transplants in early 2013
3. Half-Match Marrow Transplants Help Some With Sickle Cell
4. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
5. HIV Undetectable in 2 Men After Bone Marrow Transplants: Study
6. Noninvasive imaging technique may help kids with heart transplants
7. Protecting the hearts of those waiting for kidney and liver transplants
8. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
9. U.S. Liver Transplants Declining
10. First, Second Kidney Transplants Have Similar Success: Study
11. More changes in health care needed to fulfill promise of health information technology
Post Your Comments:
Related Image:
Stem Cell Transplants in Mice Show Promise for Lou Gehrig's Disease
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: